Search Results - Raphael Teipel

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Management of Pathological Thoracolumbar Vertebral Fractures in Patients With Multiple Myeloma: Multidisciplinary Recommendations by Georg Osterhoff, Michael Kreinest, Thomas Kuhnt, Claudia Pohlenz, Jacques Müller-Broich, Christoph Röllig, Raphael Teipel, Max J. Scheyerer, Klaus John Schnake, Ulrich J. A. Spiegl, Alexander C. Disch

    Published in Global Spine Journal (2023-04-01)
    Get full text
    Article


  2. 2

    Sequential BCMA CAR T-cell therapy in refractory multiple myeloma by Tim Richardson, Udo Holtick, Jan-Hendrik Frenking, Hishan Tharmaseelan, Hyatt Balke-Want, Ruth Flümann, Elias Karl Mai, Sandra Sauer, Raphael Teipel, Malte von Bonin, Michael Hallek, Christof Scheid, Philipp Gödel

    Published in Blood Advances (2025-09-01)
    Get full text
    Article


  3. 3

    [<sup>18</sup>F]Fluorodeoxyglucose-PET/MRI-based response assessment following BCMA-directed CAR-T-cell therapy with ciltacabtagene autoleucel in relapsed/refractory multiple myelo... by Raphael Teipel, Karolin Trautmann-Grill, Luisa Kleditsch, Katharina Epp, Sebastian Böttcher, Christoph Röllig, Heike Weidner, Andrea Gottschalk, Ingmar Glauche, Claudia Brogsitter, Ivan Platzek, Rudi Apolle, Malte von Bonin, Martin Bornhäuser, Robert Winzer, Matthias Miederer

    Published in Haematologica (2026-05-01)
    Get full text
    Article


  4. 4

    Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases by Alexander Carpinteiro, Christoph Kimmich, Despina Trajanova, Ute Hegenbart, Timon Hansen, Udo Holtick, Vera von Landenberg‐Roberg, Stephan Rainer Bohl, Raphael Teipel, Ivana von Metzler, Monika Engelhardt, Evgenii Shumilov, Maximilian Steinhardt, Hans Christian Reinhardt, Sara Oubari, Stefan Schönland

    Published in HemaSphere (2026-06-01)
    Get full text
    Article


  5. 5

    P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-383, A BCMA × CD3 BISPECIFIC T-CELL–REDIRECTING ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA by Katja Weisel, Anita D’souza, David Hurd, Peter Voorhees, Raphael Teipel, Alfred Chung, Cesar Rodriguez, Sacha Tuchman, Neha Korde, Hana Safah, Orlando Bueno, Zhongling Feng, Tanya Rosenberg, Rajvineeth Kumar Pothacamury, Jeremy Ross, Shane Lee, Ziyi Jin, Chetasi Talati, Shaji Kumar, Ravi Vij

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  6. 6

    A German multicenter real‐world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma by Jan H. Frenking, Christine Riedhammer, Raphael Teipel, Florian Bassermann, Britta Besemer, Moritz Bewarder, Jan Braune, Annamaria Brioli, Franziska Brunner, Maria Dampmann, Roland Fenk, Deniz N. Gezer, Sarah Goldman‐Mazur, Christine Hanoun, Marion Högner, Cyrus Khandanpour, Katja Kolditz, Igor Kos, Jan Krönke, Miriam Kull, Valentine Landrin, Theo Leitner, Maximilian Merz, Ivana vonMetzler, Christian S. Michel, Carsten Müller‐Tidow, Sebastian Theurich, Karolin Trautmann‐Grill, Ralph Wäsch, Romans Zukovs, Mathias Hänel, Leo Rasche, Marc S. Raab

    Published in HemaSphere (2025-04-01)
    Get full text
    Article


Search Tools: